Postprandial Glycemic Control With Automated Insulin Delivery With Control‐IQ Technology: The Impact of Meal Composition

Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST‐T1D Extension Study

To evaluate changes in glycaemic control following semaglutide discontinuation in adults with Type 1 diabetes and obesity who completed the ADJUST‐T1D randomised controlled trial.

An Observational Study on the Impact of Menstrual Cycle Phases on Carbohydrate Intake, Insulin Delivery and Glycaemia in Women With Type 1 Diabetes Using MiniMed 780G Automated Insulin Delivery System

To quantify changes in carbohydrate intake, insulin delivery and glycaemia across menstrual cycle phases in women with type 1 diabetes using the MiniMed 780G automated insulin delivery system (MM780G).

World Journal of Clinical Pediatrics

IMPACT OF PHARMACIST-LED EDUCATIONAL INTERVENTION ON GLYCAEMIC CONTROL, ANTHROPOMETRIC PARAMETERS AND HEALTHRELATED QUALITY OF LIFE IN OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE SINGLEARM INTERVENTIONAL STUDY

<jats:p>.</jats:p>

Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12‐Month Extension of a Randomized Controlled Trial

The Omnipod 5 Automated Insulin Delivery (AID) System is safe and effective for individuals managing Type 1 diabetes (T1D). Longer‐term studies may provide additional evidence of sustained effectiveness and safety of AID system use in T1D.

Real‐World Glycemic Outcomes of Open‐Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups

To assess glycemic outcomes across different age groups and explore factors associated with glycemic target achievement during 12‐months open‐source android artificial pancreas (AAPS) use among people with type 1 diabetes (T1D).